(Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that a new research ...

Epilepsy is one of the most common neurological diseases in the world, afflicting more than 50 million people. While most forms can be treated with therapeutics, patients with drug-resistant epilepsy ...

Please provide your email address to receive an email when new articles are posted on . The study analyzed 334 cases of point-of-care EEGs in the SAFER-EEG clinical trial. Overall, 79% of those with a ...